Commonwealth Equity Services’s Corbus Pharmaceuticals CRBP Stock Holding History

Commonwealth Equity Services’s Portfolio CRBP Stock Details CRBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-399	Closed	-$12K	–	3664
2021 Q3	$12K	Sell	399 -21	-5%	-$828	﹤0.01%	3558
2021 Q2	$23K	Hold	420	–	–	﹤0.01%	3494
2021 Q1	$24K	Sell	420 -131	-24%	-$8.61K	﹤0.01%	3371
2020 Q4	$20K	Sell	551 -55	-9%	-$2.06K	﹤0.01%	3174
2020 Q3	$32K	Buy	606 +202	+50%	+$36.6K	﹤0.01%	2984
2020 Q2	$101K	Buy	+404	New	+$81.6K	﹤0.01%	2767

Other funds holding CRBP

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Commonwealth Equity Services's CRBP Position: Q4 2021 in Review

Commonwealth Equity Services sold out of Corbus Pharmaceuticals (CRBP) in Q4 2021, closing a stake of 399 shares — an estimated $12K sold.

Commonwealth Equity Services first reported a position in CRBP in Q2 2020 and held it in 6 quarters. The position peaked at $101K in Q2 2020. 82 funds tracked by Wall St. Rank hold CRBP as of Q4 2021.

Commonwealth Equity Services reported no remaining Corbus Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
Commonwealth Equity Services sold 399 Corbus Pharmaceuticals shares in Q4 2021, an estimated $12K.
Commonwealth Equity Services first reported a position in Corbus Pharmaceuticals in Q2 2020 and held it in 6 quarters.
Commonwealth Equity Services's Corbus Pharmaceuticals position peaked at $101K in Q2 2020.
82 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q4 2021.

Based on Commonwealth Equity Services's 13F filing for Q4 2021, filed 31 Jan 2022.